Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA Platin CTRPv2 pan-cancer AAC -0.044 0.2
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.043 0.2
mRNA ML210 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA brivanib CTRPv2 pan-cancer AAC 0.042 0.2
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.042 0.2
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.086 0.2
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.2
Download CSV